Common Stock, Shares, Outstanding of Voyager Therapeutics, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Voyager Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Voyager Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 59,047,860, a 7.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Voyager Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 59,047,860 +4,316,544 +7.9% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 55,482,262 +940,214 +1.7% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 55,434,956 +962,843 +1.8% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 55,209,485 +891,352 +1.6% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 54,731,316 +10,692,983 +24% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 54,542,048 +10,632,887 +24% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 54,472,113 +10,712,704 +24% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 54,318,133 +10,882,244 +25% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 44,038,333 +5,424,442 +14% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 43,909,161 +5,388,825 +14% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 43,759,409 +5,320,158 +14% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 43,435,889 +5,193,920 +14% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 38,613,891 +695,496 +1.8% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 38,520,336 +738,550 +2% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 38,439,251 +667,032 +1.8% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 38,241,969 +685,914 +1.8% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 37,918,395 +550,368 +1.5% 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 37,781,786 +519,083 +1.4% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 37,772,219 +568,592 +1.5% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 37,556,055 +579,304 +1.6% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 37,368,027 +502,911 +1.4% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 37,262,703 +434,580 +1.2% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 37,203,627 +526,019 +1.4% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 36,976,751 +400,768 +1.1% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 36,865,116 +4,500,221 +14% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 36,828,123 +4,518,423 +14% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 36,677,608 +4,613,660 +14% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 36,575,983 +4,686,985 +15% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 32,364,895 +792,851 +2.5% 31 Dec 2018 10-K 03 Mar 2020 2019 FY
Q3 2018 32,309,700 +6,059,373 +23% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 32,063,948 +6,061,075 +23% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 31,888,998 +6,037,197 +23% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 31,572,044 +5,974,132 +23% 31 Dec 2017 10-K 26 Feb 2019 2018 FY
Q3 2017 26,250,327 +831,082 +3.3% 30 Sep 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 26,002,873 +726,615 +2.9% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 25,851,801 +728,404 +2.9% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 25,597,912 +666,933 +2.7% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q3 2016 25,419,245 +24,049,530 +1756% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 25,276,258 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 25,123,397 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 24,930,979 +24,116,145 +2960% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 1,369,715 30 Sep 2015 10-Q 17 Dec 2015 2015 Q3
Q4 2014 814,834 31 Dec 2014 10-K 17 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.